JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuchi, K.
Right arrow Articles by Ishida, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuchi, K.
Right arrow Articles by Ishida, Y.
Journal of Nuclear Medicine Vol. 45 No. 4 527-531
© 2004 by Society of Nuclear Medicine

Clinical Investigations

Gated Myocardial SPECT to Predict Response to ß-Blocker Therapy in Patients with Idiopathic Dilated Cardiomyopathy

Kazuki Fukuchi, MD1, Yoshio Yasumura, MD2, Keisuke Kiso, MD1,3, Kohei Hayashida, MD1, Kunio Miyatake, MD2 and Yoshio Ishida, MD1

1 Department of Radiology, National Cardiovascular Center, Suita, Osaka, Japan
2 Division of Cardiology, Department of Medicine, National Cardiovascular Center, Suita, Osaka, Japan
3 Department of Cardiology, Saka General Hospital, Shiogama, Miyagi, Japan

Because of the difficulty of predicting the response of patients with idiopathic dilated cardiomyopathy (IDC) to ß-blocker therapy, this study was performed to evaluate whether gated myocardial SPECT (gated SPECT) could be useful for predicting that response. Methods: We performed gated SPECT with 99mTc-sestamibi on 38 patients with IDC before treatment with a ß-blocker and standard medication. Perfusion abnormalities, left ventricular (LV) function, and spheric distortion were assessed by a quantitative software program. Results: We classified patients into 2 groups according to improvement in LV function after 4 mo of therapy. The groups consisted of 16 poor responders whose LV ejection fraction (LVEF) increased less than 10% and 22 good responders whose LVEF increased by 10% or more. The patient characteristics before therapy, including LV volume and LVEF, did not significantly differ between the 2 groups, but the size of the myocardial perfusion defect and spheric distortion were significantly greater in poor responders than in good responders. Conclusion: Gated SPECT, by allowing simultaneous assessment of perfusion, function and geometry, might be useful for predicting the response of patients with IDC to ß-blocker therapy.

Key Words: gated SPECT • dilated cardiomyopathy • and ß-blocker






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.